.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Novartis
Argus Health
Fuji
Johnson and Johnson
Healthtrust
QuintilesIMS
Dow
Chinese Patent Office
Federal Trade Commission

Generated: September 21, 2017

DrugPatentWatch Database Preview

Carteolol hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for carteolol hydrochloride and what is the scope of carteolol hydrochloride patent protection?

Carteolol hydrochloride
is the generic ingredient in three branded drugs marketed by Abbvie, Bausch And Lomb, Novartis, Sandoz Inc, and Apotex Inc, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for carteolol hydrochloride. Three suppliers are listed for this compound.

Summary for Generic Name: carteolol hydrochloride

Tradenames:3
Patents:0
Applicants:5
NDAs:5
Drug Master File Entries: see list4
Suppliers / Packagers: see list3
Bulk Api Vendors: see list24
Clinical Trials: see list2,278
Patent Applications: see list894
Therapeutic Class:Ophthalmic Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:carteolol hydrochloride at DailyMed

Pharmacology for Ingredient: carteolol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb
CARTEOLOL HYDROCHLORIDE
carteolol hydrochloride
SOLUTION/DROPS;OPHTHALMIC075546-001Jan 20, 2000ATRXNoNo► Subscribe► Subscribe► Subscribe
Abbvie
CARTROL
carteolol hydrochloride
TABLET;ORAL019204-002Dec 28, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Novartis
OCUPRESS
carteolol hydrochloride
SOLUTION/DROPS;OPHTHALMIC019972-001May 23, 1990DISCNYesNo► Subscribe► Subscribe► Subscribe
Sandoz Inc
CARTEOLOL HYDROCHLORIDE
carteolol hydrochloride
SOLUTION/DROPS;OPHTHALMIC075476-001Jan 3, 2000ATRXNoYes► Subscribe► Subscribe► Subscribe
Abbvie
CARTROL
carteolol hydrochloride
TABLET;ORAL019204-001Dec 28, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbvie
CARTROL
carteolol hydrochloride
TABLET;ORAL019204-003Dec 28, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Apotex Inc
CARTEOLOL HYDROCHLORIDE
carteolol hydrochloride
SOLUTION/DROPS;OPHTHALMIC076097-001Feb 6, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: carteolol hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie
CARTROL
carteolol hydrochloride
TABLET;ORAL019204-001Dec 28, 1988► Subscribe► Subscribe
Novartis
OCUPRESS
carteolol hydrochloride
SOLUTION/DROPS;OPHTHALMIC019972-001May 23, 1990► Subscribe► Subscribe
Novartis
OCUPRESS
carteolol hydrochloride
SOLUTION/DROPS;OPHTHALMIC019972-001May 23, 1990► Subscribe► Subscribe
Abbvie
CARTROL
carteolol hydrochloride
TABLET;ORAL019204-003Dec 28, 1988► Subscribe► Subscribe
Abbvie
CARTROL
carteolol hydrochloride
TABLET;ORAL019204-002Dec 28, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Mallinckrodt
Chubb
Julphar
Fish and Richardson
Express Scripts
Accenture
Medtronic
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot